4,094 Shares in Teleflex Incorporated (NYSE:TFX) Acquired by Lecap Asset Management Ltd.

Lecap Asset Management Ltd. bought a new stake in Teleflex Incorporated (NYSE:TFX - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 4,094 shares of the medical technology company's stock, valued at approximately $729,000.

Several other large investors also recently added to or reduced their stakes in the business. Simplify Asset Management Inc. acquired a new stake in shares of Teleflex in the 3rd quarter valued at $4,800,000. JPMorgan Chase & Co. raised its holdings in Teleflex by 14.3% during the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company's stock valued at $38,374,000 after buying an additional 19,466 shares in the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in shares of Teleflex by 19.8% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 484 shares of the medical technology company's stock worth $102,000 after buying an additional 80 shares during the last quarter. LGT Capital Partners LTD. boosted its stake in shares of Teleflex by 4.2% during the 3rd quarter. LGT Capital Partners LTD. now owns 231,685 shares of the medical technology company's stock worth $57,300,000 after acquiring an additional 9,411 shares in the last quarter. Finally, Boston Trust Walden Corp increased its holdings in shares of Teleflex by 3.9% during the 4th quarter. Boston Trust Walden Corp now owns 294,614 shares of the medical technology company's stock valued at $52,435,000 after acquiring an additional 11,052 shares during the last quarter. 95.62% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several research firms recently weighed in on TFX. Mizuho reduced their target price on Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a report on Friday, November 1st. StockNews.com raised Teleflex from a "hold" rating to a "buy" rating in a research report on Thursday, November 28th. Needham & Company LLC reaffirmed a "hold" rating on shares of Teleflex in a research report on Monday, December 16th. Truist Financial reduced their price objective on Teleflex from $227.00 to $200.00 and set a "hold" rating for the company in a research report on Wednesday, December 18th. Finally, Royal Bank of Canada dropped their target price on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $252.50.

Teleflex Stock Performance

Shares of NYSE:TFX traded down $0.09 during trading on Tuesday, hitting $171.37. 405,562 shares of the stock were exchanged, compared to its average volume of 513,639. The company has a market capitalization of $7.96 billion, a price-to-earnings ratio of 34.07, a price-to-earnings-growth ratio of 1.72 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a 1-year low of $169.99 and a 1-year high of $256.85. The company's fifty day simple moving average is $179.58 and its 200-day simple moving average is $210.72.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.